ALS
Former Simmons CEO Gifts UAMS $200K for ALS Research
The funds, donated by Tommy and Kathryn May, will accelerate ALS research and clinical trials. read more >
ALS Drug Will Be Pulled From US Market After Study Showed Patients Didn’t Benefit
The medication is part of a string of drugs for deadly, degenerative diseases that have won FDA approval in recent years despite questionable evidence they work. read more >
by Associated Press -
FDA Advisers Vote Against Experimental ALS Treatment
The panel of Food and Drug Administration experts voted 17-1 that drugmaker Brainstorm's stem cell-based treatment has not been shown effective for patients with the fatal, muscle-wasting disease known as ALS. read more >
by Associated Press -
FDA Skeptical of Experimental ALS Treatment Pushed by Patient Advocates
In documents posted Monday, the FDA reiterated its longstanding position that drugmaker Brainstorm's lone study doesn't provide convincing evidence that its stem cell-based therapy helps patients with ALS, or amyotrophic lateral sclerosis. read more >
by Associated Press -
Drug for Rare Form of Lou Gehrig’s Disease OK’d by FDA
It's the first drug for an inherited form of ALS, or amyotrophic lateral sclerosis, a deadly disease that destroys nerve cells needed for basic functions like walking, talking and swallowing. read more >
by Associated Press -
NIH to Fund Unproven ALS Drugs Under Patient-Backed Law
Only patients who can't get into conventional drug trials are eligible for the program. And their progress must be tracked to gather data about the treatment and their underlying disease, amyotrophic lateral sclerosis, or ALS. read more >
by Associated Press -
Sign up for Daily E-news
Sign Up
THIS WEEK’S EDITION
This Week’s Stories
View Digital Edition
